Next Article in Journal
Microencapsulated Caraway Essential Oil Affects Initial Growth of Maize Cultivars
Next Article in Special Issue
Antibacterial Activity of Pharmaceutical-Grade Rose Bengal: An Application of a Synthetic Dye in Antibacterial Therapies
Previous Article in Journal
Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me2dpb)Cl] Obtained from C‒H Activation of 1,5-Di(2-pyridyl)-2,4-dimethylbenzene (Me2dpbH)
Previous Article in Special Issue
Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assignment of Absolute Configurations of Two Promising Anti-Helicobacter pylori Agents from the Marine Sponge-Derived Fungus Aspergillus niger L14

1
School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
2
Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing 211166, China
3
College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(16), 5061; https://doi.org/10.3390/molecules26165061
Submission received: 16 July 2021 / Revised: 15 August 2021 / Accepted: 18 August 2021 / Published: 20 August 2021
(This article belongs to the Special Issue Antibacterial Agents 2021)

Abstract

:
A chemical investigation into endozoic fungus Aspergillus niger L14 derived from the marine sponge of Reniera japonica collected off Xinghai Bay (China) resulted in the isolation of two dimeric naphtho-γ-pyrones, fonsecinone A (1) and isoaurasperone A (2). Through a combination of ECD spectra and X-ray diffraction analysis, the chiral axes of compounds 1 and 2 were unambiguously determined as Rα-configurations. Bioassay results indicated that these substances exhibited remarkably inhibitory effects on human pathogens Helicobacter pylori G27 and 159 with MIC values of ≤4 μg/mL, which are similar to those of the positive control, ampicillin sodium. To the best of our knowledge, this is the first report on absolute configuration of 1 and crystallographic data of 2, as well as their potent anti-H. pylori activities.

1. Introduction

Helicobacter pylori is one of the most serious pathogenic bacteria that threaten human health, since it has infected approximately half of the world’s population [1]. Owing to decreasing effectiveness of existing antibiotic-based therapies, there is an urgent need to develop new antibiotics for the treatment of H. pylori infection [2]. As we know, most therapeutic agents currently available on the market and drug leads in clinical trial are originally derived from terrestrial microorganisms. [3] Recently, a growing body of evidence suggests that marine sponge-derived microbes are one of the more prolific sources of bioactive secondary metabolites for the development of new medicines [4,5,6,7]. Among these microorganisms, fungi in particular can produce a large number of compounds with significant bioactivities [8]. As one of the most common and important filamentous fungi in nature, Aspergillus niger possesses great potential to produce a remarkable array of substances of biomedical and agricultural relevance, as well as food enzymes [9,10,11]. Our previous bioassay of endozoic microbes from a specimen (MNP-2016) of Reniera japonica collected off Xinghai Bay (China) led to the isolation of one fungus, A. niger L14, with strong antimicrobial effects [12]. In order to extract novel bioactive compounds from this strain, fermentation and chemical investigation were carried out in this work. Herein, we report the isolation, structural elucidation and anti-Helicobacter pylori effects of two dimeric naphtho-γ-pyrones, namely fonsecinone A (1) and isoaurasperone A (2) (Figure 1). As a structurally unique metabolite, compound 1 was first isolated from A. fonsecaeus in 1984 [13], as well as from A. aculeatus [14], A. fumigatus [15] and Pleurotus ostreatus [16] more recently, while compound 2 was obtained from A. niger in 1979 for the first time and it exhibited cytotoxic and mycotoxic properties [17]. However, the compounds’ stereochemistry has not yet been determined. Therefore, the present work focus on the assignment of absolute configurations of compounds 1 and 2 by a combination of ECD spectra and single crystal X-ray diffraction analysis, as well as on the discovery of their potent anti-H. pylori effects.

2. Results and Discussion

2.1. Planar Structures of Compounds 1 and 2

Through a semi-preparative HPLC technique, compounds 1 and 2 were, respectively, separated as yellow amorphous powder from an ethyl acetate extract of a solid fermented rice of strain L14. The pseudo-molecular-ion peaks at m/z 571 ([M + H]+) and 593 ([M + Na]+) in their ESI-MS spectra suggested that 1 and 2 are isomeric (Supplementary Figures S1 and S2). On basis of their similar 1H and 13C NMR spectra [18] (Supplementary Figures S3–S6), their molecular formulas are deduced as C32H26O10. By further careful comparison of their 1H and 13C NMR spectral data with the literature (Table 1), compounds 1 and 2 were identified as fonsecinone A [14] and isoaurasperone A [19], respectively, which are dimeric naphtho-γ-pyrone analogs.

2.2. Stereochemistry of Compounds 1 and 2

The elucidation of stereogenicity or chirality of natural products plays a key role in the characterization of their structure features and biological properties [20]. In order to determine absolute configurations of compounds 1 and 2, ECD and single crystal X-ray diffraction analysis were conducted. As shown in Figure 2, ECD spectra of compounds 1 and 2 had very similar cotton effects, which one valley at 280 nm and a peak at 270 nm were respectively shown in the first negative and the positive cotton effect regions while the last elliptical valley was apparent at 220 nm in the negative cotton effect region. Moreover, their ECD spectra are completely contrary to those of S-configured aurasperones A–C [21]. Therefore, the absolute configurations of chiral axes in compounds 1 and 2 were unambiguously identified as Ra. Single crystals of 1 and 2 were successfully obtained from a mixture of chloroform and ethanol, and their crystallographic data were deposited at CCDC (Nos. 2064113 and 2064114, Figure 3). Through X-ray crystallographic analysis using Cu Kα radiation, the absolute configuration of chiral axes in 1 and 2 were verified as Ra with a GOOF2 of 1.023 and 1.042, respectively. To the best of our knowledge, ours is the first report on the absolute configuration of compound 1 and the crystallographic data of compound 2.
Crystal data for 1 is as follows: C34H34O12 (Mr = 634.61 g/mol): triclinic, space group P-1 (no. 2), a = 8.0417 (7) Å, b = 11.9593 (10) Å, c = 17.1410 (15) Å, α = 97.364 (6)°, β = 100.693 (6)°, γ = 104.037 (5)°, V = 1545.4 (2) Å3, Z = 2, T = 173.01 K, μ(GaKα) = 0.558 mm−1, Dcalc = 1.364 g/cm3, 15,365 reflections were measured (7.458° ≤ 2Θ ≤ 110.172°), 5733 unique (Rint = 0.0733, Rsigma = 0.0843), which were used in all calculations. The final R1 was 0.0956 (I > 2σ(I)) and wR2 was 0.3083 for all data. Each molecule of fonsecinone A (1) was co-crystallized with a water molecule and an ethanol molecule (Supplementary Tables S1–S4).
Crystal data for 2 is as follows: C32H26O10, (Mr = 570.53 g/mol), monoclinic, space group P21/c (no. 14), a = 11.7688 (5) Å, b = 13.7141 (7) Å, c = 17.5181 (8) Å, β = 109.295 (3)°, V = 2668.6 (2) Å3, Z = 4, T = 193.0 K, μ(GaKα) = 0.570 mm−1, Dcalc = 1.420 g/cm3, 27,052 reflections were measured (6.924° ≤ 2Θ ≤ 110.078°), 5071 unique (Rint = 0.0543, Rsigma = 0.0381), which were used in all calculations. The final R1 was 0.0508 (I > 2σ(I)) and wR2 was 0.1499 for all data. (Supplementary Tables S1, S5–S7).
CCDC Nos. 2064113 and 2064114 contain the supplementary crystallographic data for this paper. These data are freely available via http://www.ccdc.cam.ac.uk/conts/retrieving.html (accessed on 21 February 2021) or can be obtained from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk)

2.3. Antimicrobial Activity of Compounds 1 and 2

Bioassay results indicated that these bis-naphtho-γ-pyrones 1 and 2 exhibited potent antimicrobial effects on human pathogen H. pylori G27 with minimum inhibitory concentration (MIC) values of 2 μg/mL, as well as multi-drug resistant H. pylori 159 with MIC values of 2 and 4 μg/mL, respectively (Table 2). It is noteworthy that several previous reports suggested that compounds 1 and 2 had no significant bioactivity against pathogenic microbes Alternaria solani, Bacillus cereus, B. subtilis, Escherichia coli, Pseudomonas fluorescens, Trichophyton rubrum and Candida albican, and displayed a weak inhibitory effect on xanthine oxidase and no cytotoxicities against the following panel of human cancer cell lines: A2780, H1688, K562, M231, PC3, A549, MGC-803 and HL-60 [21,22,23,24,25,26]. Therefore, the present work provides an important discovery suggesting that compounds 1 and 2 are potential new drug candidates for the treatment of H. pylori infections.

2.4. Putative Biosynthetic Pathway of Compounds 1 and 2

Biosynthetically, naphtho-γ-pyrone monomers rubrofusarin B and flavasperone are aromatic polyketides, which are formed by one acetyl-CoA and six malonyl-CoA through assembly reaction catalyzed by polyketide synthase (PKS), followed by condensation, cyclization, dehydration and methylation [15,27]. Compound 2 is the dimerization product of two molecules of rubrofusarin B at C-7 and C-10, respectively, and it has been shown to be catalyzed by the pre-anthraquinone-dimerizing cytochrome P450 (CYP) enzyme encoded by the gene aunB [28] (Figure 4). Therefore, it is inferred that compound 1 is the dimerization product of rubrofusarin B and flavasperone at C-10 and C-9, respectively.

3. Materials and Methods

3.1. General Experimental Procedures

NMR spectra were collected by Bruker Avance DRX600 spectrometer (Bruker, Fällande, Switzerland) equipped with a 5 mm triple resonance (HCN) cold probe, using TMS as an internal standard. ESI-MS and HR-ESI-MS data were obtained from an Agilent 6210 LC/TOF-MS spectrometer (Agilent Technologies, Santa Clara, CA, USA). A suitable crystal was selected and measured on a Bruker APEX-II CCD diffractometer (Bruker, Fällande, Switzerland). The structure was solved with the ShelXT structure solution program using intrinsic phasing and refined with the ShelXL refinement package using least squares minimization [29]. A high performance liquid chromatography (HPLC) system, Essentia LC-16P apparatus (Shimadzu, Kyoto, Japan), equipped with a semi-preparative column (Phenomenex Hydro-RP, 250 mm × 10 mm, 4 µm, Torrance, CA, USA), was used to purify all compounds. Acetonitrile (Merck, Darmstadt, Germany) and H2O used in HPLC system were chromatographic grade, and all other chemicals were analytical grade.

3.2. Fungal Strain

Endozoic strain L14 was isolated from fresh specimens (MNP-2016) of Reniera japonica collected at Xinghai Bay (Dalian, China), as described in the literature [11], and identified as A. niger according to its morphological characteristics and molecular phylogeny based on 18S rDNA gene sequence (GenBank accession No. MF093522).

3.3. Fermentation and Extraction

First, strain L14 was cultured on potato dextrose agar (PDA) at 30 °C for 5 days. Then, a balanced amount of fungal colony was transferred to the culture broth in a 500 mL Erlenmeyer flask containing 300 mL sterilized potato dextrose broth (PDB); it was then shaken at 180 rpm for 3 days under 30 °C as seed broth. After that, the seed broth was inoculated to a solid rice medium in a 1000 mL Erlenmeyer flask with sterilized rice (160 g) and water (320 mL) and cultivated at 20 °C for 40 days. At the end of fermentation, all fermented material was collected and extracted with the same volume of ethyl acetate 3 times. The organic layer was concentrated under vacuum at 38 °C to obtain crude extract (approx. 50 g).

3.4. Isolation and Purification

The ethyl acetate extract was separated into six fractions, A-F, under a gradient condition of CH3CN and H2O on a preparative HPLC column, according to our previous established method [30]. Fraction D was further subjected to HPLC fractionation to generate fonsecinone A (1) (159.4 mg, tR = 22.6 min) and isoaurasperone A (2) (156.3 mg, tR = 24.3 min) using a semi-preparative C18 column under a gradient condition of mobile phase (CH3CN and H2O) with a flow rate of 3.0 mL/min.

3.5. Antimicrobial Assay

Human pathogen stain H. pylori G27 was a clinically susceptible strain, while multi-drug resistant clinical strain H. pylori 159 was obtained from a biopsy sample of a gastritis patient. Isolation and identification of H. pylori 159 were used standard protocols on the basis of colony appearance, Gram staining and positive reactions in the rapid urease test [31]. Then, 10% fetal calf serum (FCS) brain heart infusion (BHI) (Becton Dickinson, Sparks Glencoe, MD, USA) broth or 5% FCS Columbia blood agar (Oxoid, Basingstoke, UK), supplemented with Dent selective supplement (Oxoid, Basingstoke, UK), was used for routine culture of H. pylori strains. Incubation of strains was conducted under microaerophilic conditions (10% CO2, 85% N2, and 5% O2 and 90% relative humidity) using a double-gas CO2 incubator (Binder, model CB160, Germany) at 37 °C for 48 to 72 h. Three replicates were performed for every antimicrobial assay.
Anti-H. pylori activities were carried out according to broth microdilution assay [32]. Briefly, two-fold serial dilutions of compounds were prepared in a 96-well microtiter plate containing 100 μL of BHI broth containing 10% FCS. An overnight H. pylori liquid culture was diluted in BHI broth and was inoculated into each well with a final concentration of 5 × 105 CFU/mL. After being incubated in a microaerophilic atmosphere at 37 °C for 2 days, the plates were examined visually. The MIC was determined to be the lowest concentration with no turbidity in well. For quality control and comparative analysis, the conventional antibiotics metronidazole (MTZ), clarithromycin (CLR) and levofloxacin (LVX) were tested as positive control. All MIC assays were performed in triplicate at least. Antimicrobial activity testing of each compound followed antimicrobial susceptibility testing standards outlined by the document M07-A7 (Clinical and Laboratory Standards Institute 2008) against strains G27 and Hp159.

Supplementary Materials

The following are available online, Figure S1: ESI-MS spectrum of compound 1, Figure S2: ESI-MS spectrum of 2, Figure S3: 1H NMR spectrum (600 MHz, CDCl3) of 1, Figure S4: 13C NMR spectrum (150 MHz, CDCl3) of 1, Figure S5: 1H NMR spectrum (600 MHz, CDCl3) of 2, Figure S6: 13C NMR spectrum (150 MHz, CDCl3) of 2, Figure S7: Crystallographic shape of 1 and 2, Table S1: Selected crystal data and refinement parameters for 1 and 2, Table S2: Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) for 1, Table S3: Bond lengths [Å] and angles [°] for 1, Table S4: Hydrogen coordinates (× 104) and isotropic displacement parameters (Å2 × 103) for 1, Table S5: Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) for 2, Table S6: Bond lengths [Å] and angles [°] for 2, Table S7: Hydrogen coordinates (× 104) and isotropic displacement parameters (Å2 × 103) for 2.

Author Contributions

R.Y. and J.L. performed fermentation of the fungus, isolation and structure determination of the compounds and wrote the draft. J.J. conducted anti-H. pylori assay of all compounds. H.Z. designed the experiment and revised the manuscript. W.G. elucidated the crystal structures of all compounds. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Key R&D Program of China (2018YFC0311004), the National Natural Science Foundation of China (41776139), and the Fundamental Research Fund for the Provincial Universities of Zhejiang of China (RF-C2019002).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Strain L14 and compounds 1 and 2 are available from the authors.

References

  1. Zamani, M.; Ebrahimtabar, F.; Zamani, V.; Miller, W.H.; Alizadeh-Navaei, R.; Shokri-Shirvani, J.; Derakhshan, M.H. Systematic review with meta-analysis: The worldwide prevalence of Helicobacter pylori infection. Aliment. Pharm. Ther. 2018, 47, 868–876. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Savoldi, A.; Carrara, E.; Graham, D.Y.; Conti, M.; Tacconelli, E. Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and meta-analysis in world health organization regions. Gastroenterology 2018, 155, 1372–1382. [Google Scholar] [CrossRef] [Green Version]
  3. Peyrat, L.A.; Tsafantakis, N.; Georgousaki, K.; Ouazzani, J.; Genilloud, O.; Trougakos, I.P.; Fokialakis, N. Terrestrial microorganisms: Cell factories of bioactive molecules with skin protecting applications. Molecules 2019, 24, 1836. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Storey, M.A.; Andreassend, S.K.; Bracegirdle, J.; Brown, A.; Keyzers, R.A.; Ackerley, D.F.; Northcote, P.T.; Owen, J.G. Metagenomic exploration of the marine sponge Mycale hentscheli uncovers multiple polyketide-producing bacterial symbionts. MBio 2020, 11, e02997-19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Brinkmann, C.M.; Kearns, P.S.; Evans-Illidge, E.; Kurtboke, D.I. Diversity and bioactivity of marine bacteria associated with the sponges Candidaspongia flabellata and Rhopaloeides odorabile from the Great Barrier Reef in Australia. Diversity 2017, 9, 39. [Google Scholar] [CrossRef] [Green Version]
  6. Zhang, H.W.; Zhao, Z.P.; Wang, H. Cytotoxic natural products from marine sponge-derived microorganisms. Mar. Drugs 2017, 15, 68. [Google Scholar] [CrossRef] [Green Version]
  7. Tortorella, E.; Tedesco, P.; Esposito FPJanuary, G.G.; Fani, R.; Jaspars, M.; de Pascale, D. Antibiotics from deep-sea microorganisms: Current discoveries and perspectives. Mar. Drugs 2018, 16, 355. [Google Scholar] [CrossRef] [Green Version]
  8. Wethalawe, A.N.; Alwis, Y.V.; Udukala, D.N.; Paranagama, P.A. Antimicrobial compounds isolated from endolichenic fungi: A review. Molecules 2021, 26, 3901. [Google Scholar] [CrossRef] [PubMed]
  9. Lima, M.A.S.; de Oliveira, M.D.F.; Pimenta, A.T.A.; Uchoa, P.K.S. Aspergillus niger: A hundred years of contribution to the natural products chemistry. J. Brazil. Chem. Soc. 2020, 30, 2029–2059. [Google Scholar] [CrossRef]
  10. Li, C.; Zhou, J.W.; Du, G.C.; Chen, J.; Takahashi, S.; Liu, S. Developing Aspergillus niger as a cell factory for food enzyme production. Biotechnol. Adv. 2020, 44, 107630. [Google Scholar] [CrossRef]
  11. Yu, R.L.; Liu, J.; Wang, Y.; Wang, H.; Zhang, H.W. Aspergillus niger as a secondary metabolite factory. Front. Chem. 2021, 9, 701022. [Google Scholar] [CrossRef]
  12. Bai, X.L.; Dong, M.L.; Lai, T.F.; Zhang, H.W. Antimicrobial evaluation of the crude extract of symbiotic fungi from marine sponge Reniera japonica. Bangladesh J. Pharmacol. 2018, 13, 53–56. [Google Scholar] [CrossRef] [Green Version]
  13. Priestap, H.A. New naphthopyrones from Aspergillus fonsecaeus. Tetrahedron 1984, 40, 3617–3624. [Google Scholar] [CrossRef]
  14. Campos, F.R.; Barison, A.; Daolio, C.; Ferreira, A.G.; Rodrigues-Fo, E. Complete 1H and 13C NMR assignments of aurasperone A and fonsecinone A, two bis-naphthopyrones produced by Aspergillus aculeatus. Magn. Reson. Chem. 2005, 43, 962–965. [Google Scholar] [CrossRef]
  15. Hua, Y.; Pan, R.; Bai, X.L.; Wei, B.; Chen, J.W.; Wang, H.; Zhang, H.W. Aromatic polyketides from a symbiotic strain Aspergillus fumigatus D and characterization of their biosynthetic gene D8.t287. Mar. Drugs 2020, 18, 324. [Google Scholar] [CrossRef]
  16. Cai, X.; Yu, H.; Yu, Y.; Li, Q.; Chen, B.; Huang, Y.; Zou, X.; Huang, B.; Tang, J. Separation of five naphtho-gamma-pyrones from Pleurotus ostreatus by high-speed countercurrent chromatography. J. Sep. Sci. 2018, 41, 4551–4558. [Google Scholar] [CrossRef]
  17. Ghosal, S.; Biswas, K.; Chakrabarti, D.K. Toxic naphtho-gamma-pyrones from Aspergillus niger. J. Agric. Food Chem. 1979, 27, 1347–1351. [Google Scholar] [CrossRef] [PubMed]
  18. Priestap, H.A. 13C NMR spectroscopy of naphtho-γ-pyrones. Magn. Reson. Chem. 1986, 24, 875–878. [Google Scholar] [CrossRef]
  19. Xu, K.; Guo, C.; Shi, D.; Meng, J.; Tian, H.; Guo, S. Discovery of natural dimeric naphthopyrones as potential cytotoxic agents through ROS-mediated apoptotic pathway. Mar. Drugs 2019, 17, 207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Menna, M.; Imperatore, C.; Mangoni, A.; Della, S.G.; Taglialatela, S.O. Challenges in the configuration assignment of natural products. A case-selective perspective. Nat. Prod. Rep. 2019, 36, 476–489. [Google Scholar] [CrossRef]
  21. Li, X.B.; Xie, F.; Liu, S.-S.; Li, Y.; Zhou, J.C.; Liu, Y.Q.; Yuan, H.Q.; Lou, H.-X. Naphtho-γ-pyrones from endophyte Aspergillus niger occurring in the liverwort Heteroscyphus tener (Steph.) Schiffn. Chem. Biodivers. 2013, 10, 1193–1201. [Google Scholar] [CrossRef]
  22. Shaaban, M.; Shaaban, K.A.; Abdel-Aziz, M.S. Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: Structure elucidation and biological properties. Org. Med. Chem. Lett. 2012, 2, 6. [Google Scholar] [CrossRef] [Green Version]
  23. Song, Y.C.; Li, H.; Ye, Y.H.; Shan, C.Y.; Yang, Y.M.; Tan, R.X. Endophytic naphthopyrone metabolites are co-inhibitors of xanthine oxidase, SW1116 cell and some microbial growths. FEMS Microb. Lett. 2004, 241, 67–72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Xiao, J.; Zhang, Q.; Gao, Y.Q.; Shi, X.W.; Gao, J.-M. Antifungal and antibacterial metabolites from an endophytic Aspergillus sp. associated withMelia azedarach. Nat. Prod. Res. 2014, 28, 1388–1392. [Google Scholar] [CrossRef] [PubMed]
  25. Padhi, S.; Masi, M.; Panda, S.K.; Luyten, W.; Cimmino, A.; Tayung, K.; Evidente, A. Antimicrobial secondary metabolites of an endolichenic Aspergillus niger isolated from lichen thallus of Parmotrema ravum. Nat. Prod. Res. 2020, 34, 2573–2580. [Google Scholar] [CrossRef] [PubMed]
  26. Li, D.H.; Han, T.; Guan, L.P.; Bai, J.; Zhao, N.; Li, Z.L.; Wu, X.; Hua, H.M. New naphthopyrones from marine-derived fungus Aspergillus niger 2HL-M-8 and their in vitro antiproliferative activity. Nat. Prod. Res. 2016, 30, 1116–1122. [Google Scholar] [CrossRef] [PubMed]
  27. Chiang, Y.M.; Meyer, K.M.; Praseuth, M.; Baker, S.E.; Bruno, K.S.; Wang, C.C.C. Characterization of a polyketide synthase in Aspergillus niger whose product is a precursor for both dihydroxynaphthalene (DHN) melanin and naphtho-γ-pyrone. Fungal Genet. Biol. 2011, 48, 430–437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Obermaier, S.; Müller, M. Biaryl-forming enzymes from Aspergilli exhibit substrate-dependent stereoselectivity. Biochemistry 2019, 58, 2589–2593. [Google Scholar] [CrossRef]
  29. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Cryst. C 2015, 71, 3–8. [Google Scholar] [CrossRef]
  30. Chen, J.W.; Bai, X.L.; Hua, Y.; Zhang, H.W.; Wang, H. Fusariumins C and D, two novel antimicrobial agents from Fusarium oxysporum ZZP-R1 symbiotic on Rumex madaio Makino. Fitoterapia 2019, 134, 1–4. [Google Scholar] [CrossRef]
  31. Castellote, J.; Guardiola, J.; Porta, F.; Falco, A. Rapid urease test: Effect of preimmersion of biopsy forceps in formalin. Gastrointest. Endosc. 2001, 53, 744–746. [Google Scholar] [CrossRef] [PubMed]
  32. Covacci, A.; Censini, S.; Bugnoli, M.; Petracca, R.; Burroni, D.; Macchia, G.; Massone, A.; Papini, E.; Xiang, Z.; Figura, N.; et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 1993, 90, 5791–5795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Chemical structures of compounds 1 and 2 from Aspergillus niger L14.
Figure 1. Chemical structures of compounds 1 and 2 from Aspergillus niger L14.
Molecules 26 05061 g001
Figure 2. Experimental ECD spectra of compounds 1 and 2.
Figure 2. Experimental ECD spectra of compounds 1 and 2.
Molecules 26 05061 g002
Figure 3. ORTEP drawings of compounds 1 and 2.
Figure 3. ORTEP drawings of compounds 1 and 2.
Molecules 26 05061 g003
Figure 4. Putative biosynthetic pathways of compounds 1 and 2.
Figure 4. Putative biosynthetic pathways of compounds 1 and 2.
Molecules 26 05061 g004
Table 1. 13C and 1H NMR spectral data for compounds 1 and 2.
Table 1. 13C and 1H NMR spectral data for compounds 1 and 2.
Compound12
PositionδC aδH bδC aδH b
2167.6 167.7
3110.86.32 (1H, s)107.66.06 (1H, s)
4183.1 184.7
4a109.5 104.9
5156.8 162.1
5a/ 111.6
6106.27.04 (1H, s)158.7
6a140.9 /
7101.76.97 (1H, s)117.8
8160.2 160.3
9117.3 101.56.97 (1H, s)
9a/ 140.8
10157.1 101.47.16 (1H, s)
10a108.1 153.5
10 b155.2 /
2-Me20.72.48 (3H, s)212.42 (3H, s)
5-OH 12.82 (1H, s)
6-OMe/ 62.23.46 (3H, s)
8-OMe56.13.78 (3H, s)56.13.79 (3H, s)
3.43 (3H, s)
10-OMe61.23.78 (3H, s)/3.43 (3H, s)
3.43 (3H, s)
2′167 167.8
3′107.55.99 (1H, s)107.45.98 (1H, s)
4′184.7 184.6
4′a104.4 104.4
5′163 162.9
5′a108.8 108.7
6′161.3 161.2
7′97.16.42 (1H, d)976.42 (1H, s)
8′161.8 161.5
9′96.56.19 (1H, d)96.76.21 (1H, s)
9′a140.8 140.7
10′105.2 105.3
10′a151 151
2′-Me20.82.12 (3H, s)20.82.12 (3H, s)
5′-OH 15.23 (1H, s)
6′-OMe56.44.02 (3H, s)56.44.03 (3H, s)
8′-OMe55.33.61 (3H, s)55.33.62 (3H, s)
a: in CDCl3, 150 MHz; b: in CDCl3, 600 MHz.
Table 2. In vitro anti-Helicobacter pylori effects of compounds 1 and 2.
Table 2. In vitro anti-Helicobacter pylori effects of compounds 1 and 2.
CompoundMIC Value (μg/mL)
Strain G27 (S)Strain 159 (R)
122
224
MTZ216
CLR0.0042
LVX0.58
Note: Antimicrobial susceptibility breakpoints were determined according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. S, drug susceptible; R, drug resistant; MTZ, metronidazole; CLR, clarithromycin; LVX, levofloxacin.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Liu, J.; Yu, R.; Jia, J.; Gu, W.; Zhang, H. Assignment of Absolute Configurations of Two Promising Anti-Helicobacter pylori Agents from the Marine Sponge-Derived Fungus Aspergillus niger L14. Molecules 2021, 26, 5061. https://doi.org/10.3390/molecules26165061

AMA Style

Liu J, Yu R, Jia J, Gu W, Zhang H. Assignment of Absolute Configurations of Two Promising Anti-Helicobacter pylori Agents from the Marine Sponge-Derived Fungus Aspergillus niger L14. Molecules. 2021; 26(16):5061. https://doi.org/10.3390/molecules26165061

Chicago/Turabian Style

Liu, Jia, Ronglu Yu, Jia Jia, Wen Gu, and Huawei Zhang. 2021. "Assignment of Absolute Configurations of Two Promising Anti-Helicobacter pylori Agents from the Marine Sponge-Derived Fungus Aspergillus niger L14" Molecules 26, no. 16: 5061. https://doi.org/10.3390/molecules26165061

Article Metrics

Back to TopTop